[1] Jarcho M., Kay J.F., Gumar K.I., Doremus R.H., Drobeck H.P., Tissue, cellular and subcellular events at a bone-ceramic hydroxyapatite interface, J. Biosci. Bioeng., 1977, 1, 79–91 Google Scholar

[2] Kokubo T., Kim H.-M., Kawashita M., Novel bioactive materials with different mechanical properties, Biomaterials, 2003, 24, 2161–2175 http://dx.doi.org/10.1016/S0142-9612(03)00044-9CrossrefGoogle Scholar

[3] Sopyan I., Mel M., Ramesh S., Khalid K.A., Porous hydroxyapatite for artificial bone applications, Sci. Tech. Adv. Mater., 2007, 8, 116–123 http://dx.doi.org/10.1016/j.stam.2006.11.017CrossrefGoogle Scholar

[4] Sudo A., Hasegawa M., Fukuda A., Uchida A., Treatment of infected hip arthroplasty with antibiotic-impregnated calcium hydroxyapatite, J. Arthroplasty, 2008, 23, 145–150 http://dx.doi.org/10.1016/j.arth.2006.09.009CrossrefGoogle Scholar

[5] Chu Ch., Guo J., Qu J., Hu X., Efficient destruction of bacteria with Ti(IV) and antibacterial ions in cosubstituted hydroxyapatite films, Appl. Cat., 2007, 73, 345–353 http://dx.doi.org/10.1016/j.apcatb.2007.01.006CrossrefGoogle Scholar

[6] Yoshikawa M., Tsuji N., Toda T., Ohgushi H., Osteogenic effect of hyaluronic acid sodium salt in the pores of a hydroxyapatite scaffold, Mat. Sci. Engn., 2007, 27, 220–226 http://dx.doi.org/10.1016/j.msec.2006.05.014CrossrefGoogle Scholar

[7] Joosten U., Joist A., Gosheger G., Liljenqvist U., Brandt B., von Eiff Ch., Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis, Biomaterials, 2005, 26, 5251–5258 http://dx.doi.org/10.1016/j.biomaterials.2005.01.001CrossrefGoogle Scholar

[8] Tian X.B., Wang Z.M., Yang S.Q., Luo Z.J., Fu R.K.Y., Chu P.K., Antibacterial copper-containing titanium nitride films produced by dual magnetron sputtering, Surf. Coat. Technol., 2007, 201, 8606–8609 http://dx.doi.org/10.1016/j.surfcoat.2006.09.322CrossrefGoogle Scholar

[9] Netz D.J.A., Sepulveda P., Pandolfelli V.C., Spadaro A.C.C., Alencastre J.B., Bentley M.V.L.B., et al., Potential use of gelcasting hydroxyapatite porous ceramic as implantable drug delivery system, Int. J. Pharm., 2001, 213, 117–125 http://dx.doi.org/10.1016/S0378-5173(00)00659-1CrossrefGoogle Scholar

[10] Nair M.B., Babu S.S., Varma H.K., John A., A triphasic ceramic-coated porous hydroxyapatite for tissue engineering application, Acta Biomat., 2008, 4, 173–181 http://dx.doi.org/10.1016/j.actbio.2007.07.004CrossrefGoogle Scholar

[11] Tsioptsias C., Panayiotou C., Preparation of cellulose-nanohydroxyapatite composite scaffolds from ionic liquid solutions, Carbohydr. Polymers, 2008, 74, 99–105 http://dx.doi.org/10.1016/j.carbpol.2008.01.022CrossrefGoogle Scholar

[12] Xu Q., Tanaka Y., Czernuszka J.T., Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes, Biomaterials, 2007, 28, 2687–2694 http://dx.doi.org/10.1016/j.biomaterials.2007.02.007CrossrefGoogle Scholar

[13] Bharati S., Soundrapandian Ch., Basu D., Datta D., Studies on a novel bioactive glass and composite coating with hydroxyapatite on titanium based alloys: Effect of Γ-sterilization on coating, J. Eur. Cer. Society, 2009, 29, 2527–2535 http://dx.doi.org/10.1016/j.jeurceramsoc.2009.02.013CrossrefGoogle Scholar

[14] Shor L., Güçeri S., Wen X., Gandhi M., Sun W., Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblastscaffold interactions in vitro, Biomaterials, 2007, 28, 5291–5297 http://dx.doi.org/10.1016/j.biomaterials.2007.08.018CrossrefGoogle Scholar

[15] Porter A.E., Botelho C.M., Lopes M.A., Santos J.D., Best S.M., Bonfield W., Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo, J. Biomed. Mater. Res. A., 2004, 69, 670–679 http://dx.doi.org/10.1002/jbm.a.30035CrossrefGoogle Scholar

[16] Chang B.-S., Lee C.-K., Hong K.-S., Youn H.-J., Ryu H.-S., Chung S.-S., et al., Osteoconduction at porous hydroxyapatite with various pore configurations, Biomaterials, 2000, 21, 1291–1298 http://dx.doi.org/10.1016/S0142-9612(00)00030-2CrossrefGoogle Scholar

[17] Esteban S.L., Suarez T.R., Betegón F.E., Pecharromán C., Moya J.S., Mechanical properties and interfaces of zirconia/nickel in micro- and nanocomposites, J. Mater. Sci., 2006, 41, 5194–5199 http://dx.doi.org/10.1007/s10853-006-0441-9CrossrefGoogle Scholar

[18] Le Nihouannen D., Le Guehennec L., Rouillon P., Bilban M., Layrolle P., Daculsi G., Microarchitecture of calcium phosphate granules and fibrin flue composites for bone tissue engineering, Biomaterials, 2006, 27, 2716–2722 http://dx.doi.org/10.1016/j.biomaterials.2005.11.038CrossrefGoogle Scholar

[19] Le Nihouannen D., Saffarzadeh A., Aguado E., Goyenvalle E., Gauthier O., Moreau F., et al., Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites, J. Mater. Sci. Mater. Med., 2007, 18, 225–235 http://dx.doi.org/10.1007/s10856-006-0684-7CrossrefGoogle Scholar

[20] Zhan X.-B., Lin Ch.-Ch., Zhang H.-T., Recent advances in curdlan biosynthesis, biotechnological production and applications, Appl. Microbiol. Biotechnol., 2012, 93, 525–531 http://dx.doi.org/10.1007/s00253-011-3740-2CrossrefGoogle Scholar

[21] Kanke M., Katayama H., Nakamura M., Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro, Biol. Pharm. Bull., 1995, 18, 1104–1108 http://dx.doi.org/10.1248/bpb.18.1104CrossrefGoogle Scholar

[22] Kanke M., Tanabe E., Katayama H., Koda Y., Nakamura M., Application of curdlan to controlled drug delivery. II. In vitro and in vivo drug release studies of theophylline-containing curdlan tablets, Biol. Pharm. Bull., 1995, 18, 1154–1158 http://dx.doi.org/10.1248/bpb.18.1154CrossrefGoogle Scholar

[23] Subedi R.K., Kang K.W., Choi H.-K., Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin, Eur. J. Pharm. Sci., 2009, 37, 508–513 http://dx.doi.org/10.1016/j.ejps.2009.04.008CrossrefGoogle Scholar

[24] Li L., Gao F.P., Tang H.B., Bai Y.G., Li R.F., Li X.M., et al., Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin, Nanotech., 2010, 21, 265–601 Google Scholar

[25] Bolcal C., Yildimir V., Doganci S., Sargin M., Aydin A., Eken A., et al., Protective effects of antioxidant medications on limb ischemia reperfusion injury, J. Surg. Res., 2007, 139, 274–279 http://dx.doi.org/10.1016/j.jss.2006.10.043CrossrefGoogle Scholar

[26] Berdal M., Appelbom H.I., Eikrem J.H., Lund Å., Zykova S., Busund L.T., et al., Aminated β-1,3-glucan improves wound healing in diabetic db/db mice, Wound Rep. Reg., 2007, 15, 825–832 http://dx.doi.org/10.1111/j.1524-475X.2007.00286.xCrossrefGoogle Scholar

[27] Bohn J.A., BeMiller J.N., (1→3)-β-D-glucans as biological response modifiers: a review of structurefunctional activity relationships, Carbohydrate Polymers., 1995, 28, 3–14 http://dx.doi.org/10.1016/0144-8617(95)00076-3CrossrefGoogle Scholar

[28] Oliveira R.J., Matuo R., da Silva A.F., Matiazi H.J., Mantovani M.S., Ribeiro L.R., Protective effect of β-glucan extracted rom Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (k1) and repair-deficient (xrs5) CHO cells, Toxicology in Vitro, 2007, 21, 41–52 http://dx.doi.org/10.1016/j.tiv.2006.07.018CrossrefGoogle Scholar

[29] Greinacher A., Alban S., Dummel V., Franz G., Mueller-Eckhardt C., Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia, Thromb. Haemost., 1995, 74, 886–892 Google Scholar

[30] Morikawa K., Takeda R., Yamazaki M., Mizuno D., Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear β-1,3-D-glucan and other immunomodulators in murine cells, Cancer Res., 1985, 45, 1496–1501 Google Scholar

[31] Bøgwald J., Gouda I., Hoffman J., Larm O., Larsson R., Seljelid R., Stimulatory effect of immobilized glycans on macrophages in vitro, Scand. J. Immunol., 1987, 20, 355–360 http://dx.doi.org/10.1111/j.1365-3083.1984.tb01013.xCrossrefGoogle Scholar

[32] Belcarz A., Ginalska G., Ślósarczyk A., Paszkiewicz Z., Bioactive composite and process for the production of the bioactive composite, Polish Patent PL-387872, 2009 Google Scholar

[33] Belcarz A., Ginalska G., Ślósarczyk A., Paszkiewicz Z., Bioactive composite and process for the production of the bioactive composite, European Patent Office, EP 107266397, 2010 Google Scholar

[34] Paszkiewicz Z., Ślósarczyk A., Zima A., Method for fabrication of highly porous, calcium phosphate bioactive implant material, Polish Patent PL-387530, 2009 Google Scholar

[35] Kokubo T., Hushitani H., Sakka S., Kitsugi T., Yamamuro T., Solutions able to reproduce in vivo surface-structure changes in bioactive glassceramic A-W., J. Biomed. Mater. Res., 1990, 24, 721–734 http://dx.doi.org/10.1002/jbm.820240607CrossrefGoogle Scholar

[36] ISO 23317:2007 (E), International Organization for Standardization (ISO), Implants for surgery — In vitro evaluation for apatite-forming ability of implant materials, Geneva: International Organization for Standardization, 2007 Google Scholar

[37] Oliveira J.M., Rodrigues M.T., Silva S.S., Malayafa P.B., Gomes M.E., Viegas C.A., et al., Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells, Biomaterials, 2006, 27, 6123–6137 http://dx.doi.org/10.1016/j.biomaterials.2006.07.034CrossrefGoogle Scholar

[38] Rapacz-Kmita A., Paluszkiewicz C., Ślósarczyk A., Paszkiewicz Z., FTIR and XRD investigations on the thermal stability of hydroxyapatite during hot pressing and pressureless sintering process, J. Mol. Structure, 2005, 744–747, 653–656 http://dx.doi.org/10.1016/j.molstruc.2004.11.070CrossrefGoogle Scholar

[39] Wang Y.-J., Yao S.-H., Guan Y.-X., Wu T.-X., Kennedy J.F., A novel process for preparation of (1→3)-β-D-glucan sulphate by a heterogeneous reaction and its structural elucidation, Carbohyd. Polym., 2005, 59, 93–99 http://dx.doi.org/10.1016/j.carbpol.2004.09.003CrossrefGoogle Scholar

[40] Jin Y., Zhang H., Yin Y., Nishinari K., Comparison of curdlan and its carboxymethylated derivative by means of Rheology, DSC and AFM, Carbohyd. Res., 2006, 341, 90–99 http://dx.doi.org/10.1016/j.carres.2005.11.003CrossrefGoogle Scholar

[41] Liu Y., Lu Y., Tian X., Cui G., Zhao Y., Yang Q., et al., Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model, Biomaterials, 2009, 30, 6276–6285 http://dx.doi.org/10.1016/j.biomaterials.2009.08.003Google Scholar

[42] Linkow L.I., Implant dentistry today: a multidisciplinary approach, Vol. I. Piccin Nuova Libraria, Padua, Italy, 1990 Google Scholar

[43] Ślósarczyk A., Ceramic biomaterials [Biomateriały ceramiczne], In: Błażewicz S., Stoch L. (Eds.), Biocybernetyka i Inżynieria Biomedyczna 2000, V.1: Biomateriały, Akademicka Oficyna Wydawnicza EXIT, Warsaw, 2003 (in Polish) Google Scholar

[44] Aoki H., Medical applications of hydroxyapatite, Ishiyaki EuroAmerica Inc, Tokyo St. Louis, 1994 Google Scholar

[45] Zheng-Qiu G., Jiu-Mei X., Xiang-Hong Z., The development of artificial articular cartilage-PVAhydrogel, Biomed. Mater. Eng., 1998, 8, 75–81 Google Scholar

[46] Magnussen R.A., Guilak F., Vail T.P., Cartilage degeneration in post-collapse cases of osteonecrosis of the human femoral head: altered mechanical properties in tension, compression and shear, J. Orthop. Res., 2005, 23, 576–583 http://dx.doi.org/10.1016/j.orthres.2004.12.006CrossrefGoogle Scholar

[47] Suchanek W., Yoshimura M., Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement, J. Mater. Res., 1998, 13, 94–117 http://dx.doi.org/10.1557/JMR.1998.0015CrossrefGoogle Scholar

[48] Bonfield W., Bowman J.A., Grynpas M.D., Composite material for use in orthopaedics, US Patent 5017627, 1991 Google Scholar

[49] Noah E.M., Chen J., Jiao X., Heschel L., Pallua N., Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering, Biomaterials, 2002, 23, 2855–2861 http://dx.doi.org/10.1016/S0142-9612(01)00412-4CrossrefGoogle Scholar

[50] Kawashita M., Nakao M., Minoda M., Kim H.M., Beppu T., Miyamoto T., et al., Apatite-forming ability of carboxyl group-containing polymer gels in a simulated body fluid, Biomaterials, 2001, 24, 2477–2484 http://dx.doi.org/10.1016/S0142-9612(03)00050-4CrossrefGoogle Scholar

[51] Chen J., Duan Y., Zhang X., Effect of microstructure on osteoinductivity of biomaterials, Key Engin. Mater., 2005, 284–286, 289–292 http://dx.doi.org/10.4028/www.scientific.net/KEM.284-286.289CrossrefGoogle Scholar

[52] Habibovic P., Yuan H., van der Valk C.M., Meijer G., van Blitterswijk C.A., de Groot K., 3D microenvironment as essential element for osteoinduction by biomaterials, Biomaterials, 2005, 26, 3565–3575 http://dx.doi.org/10.1016/j.biomaterials.2004.09.056CrossrefGoogle Scholar

[53] Hornez J.-C., Chai F., Monchau F., Blanchemain N., Descamps M., Hildebrandt H.F., Biological and physico-chemical assessment of hydroxyapatite (HA) with different porosity, Biomol. Engn., 2007, 24, 505–509 http://dx.doi.org/10.1016/j.bioeng.2007.08.015CrossrefGoogle Scholar

[54] Abrahams J.J., Berger S.B., Oral-maxillary sinus fistula (oroantral fistula): clinical features and findings on multiplanar CT, Am. Roentgen Ray Soc., 1995, 165, 1273–1276 http://dx.doi.org/10.2214/ajr.165.5.7572517CrossrefGoogle Scholar

[55] Liu Y.L., Schoenaers J., de Groot K., de Wijn J.R., Schepers E., Bone healing in porous implants: a histological and histometrical comparative study on sheep, J. Mater. Sci.: Mater. Med., 2000, 11, 711–717 http://dx.doi.org/10.1023/A:1008971611885CrossrefGoogle Scholar

[56] Lee S.B., Jeon H.W., Lee Y.W., Lee Y.M., Song K.W., Park M.H., et al., Bio-artificial skin composed of gelatin and (1→3), (1→6)-β-glucan, Biomaterials, 2003, 24, 2503–2511 http://dx.doi.org/10.1016/S0142-9612(03)00003-6CrossrefGoogle Scholar

[57] Khandwekar A.P., Patil D.P., Khandwekar V., Shouche Y.S., Sawant S., Doble M., TecoflexTM functionalization by curdlan and its effect on protein adsorption and bacterial and tissue cell adhesion, J. Mater. Sci. Mater. Med., 2009, 20, 1115–1129 http://dx.doi.org/10.1007/s10856-008-3655-3CrossrefGoogle Scholar

[58] Sun Y., Liu Y., Li Y., Lv M., Li P., Xu H., et al., Preparation and characterization of novel curdlan/chitosan blending membranes for antibacterial applications, Carbohydrate Polymers, 2011, 84, 952–959 http://dx.doi.org/10.1016/j.carbpol.2010.12.055CrossrefGoogle Scholar

[59] Delatte S.J., Evans J., Hebra A., Adamson W., Otherson H.B., Tagge E.P., Effectiveness of betaglucan collagen for treatment of partial-thickness burns in children, J. Pediatric Surg., 2001, 36, 113–118 http://dx.doi.org/10.1053/jpsu.2001.20024CrossrefGoogle Scholar